Definitive radiotherapy for stage I non-small cell lung cancer: Ain't nothing like the real thing?

Journal of Thoracic Oncology

Volumn 1, Issue 8, 2006, Pages 763-765

  Bogart, Jeffrey A ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; EARLY CANCER; EDITORIAL; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MULTIVARIATE ANALYSIS; NON INVASIVE PROCEDURE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; STEREOTAXIC SURGERY; SURVIVAL RATE; SURVIVAL TIME; LUNG TUMOR; NOTE; RADIOSURGERY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE;

EID: 34248394786     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200610000-00001     Document Type: Editorial

References (32)

1. Jemal A, Murray T, Ward A, et al. Cancer statistics, 2005. CA Cancer J Clin 2006;55:10-30.
2. Havlik RJ, Yancik R, Long S, et al. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994;74:2101-2106.
3. McGarry RC, Song G, des Rosiers P, et al. Observation-only management of early stage, medically inoperable lung cancer. Chest 2002;121:1155-1158.
4. Kyasa MJ, Jazieh AR. Characteristics and outcomes of patients with unresected earlystage non-small cell lung cancer. South Med J 2002;95:1149-1152.
5. Sibley GS. Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma: smaller volume and higher doses-a review. Cancer 1998;82:433-438, Review.
6. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001;56:628-638.
7. Miller JI, Hatcher CR. Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function. Ann Thorac Surg 1987;44:340-343.
8. d'Amato TA, Galloway M, Szydlowski G, et al. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest 1998;114:1112-1115.
9. Lee W, Daly DB, Dipetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 2003;75:237-242.
10. Bush DA, Slater JD, Shin BB, et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 2004;126:1198-1203.
11. Koto M, Miyamoto T, Yamamoto N, et al. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol 2004;71:147-156.
12. Fernando H, De Hoyos A, Landreneau R, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2006;129:639-644.
13. Shennib H, Bogart J, Herndon JE, et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovas Surg 2006;129:813-818.
14. Errett LE, Wilson J, Chiu RC, et al. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg 1985;90:656-661.
15. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997;113:691-698.
16. Yano T, Yokoyama H, Yoshino I, et al. Results of limited resection for compromised or poor-risk patients with clinical stage I non-small cell carcinoma of the lung. J Am Coll Surg 1995;181:33-37.
17. Noordijk EM, Clement E, Hermans J, et al. Radiotherapy as an alternative to surgery in elderly patients with randomized lung cancer. Radiother Oncol 1988;13:83-89.
18. Graham PH, Vinod SK, Hui AC. Stage I non-small-cell lung cancer: results for surgery in a patterns-of-care study in Sydney and for high-dose concurrent end-phase boost-accelerated radiotherapy. J Thorac Oncol 2006;1:796-801.
19. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 2001;19:127-136.
20. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2006;61:318-328.
21. Henning GT, Littles JF, Martel ML, et al. Preliminary results of 92.4 Gy or more for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2002;48 (Suppl 1):233.
22. Fowler JF, Chappell R. Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 2000;46:516-517.
23. Saunders M, Dische S, Barrett A, et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: a randomized multicentre trial. CHART Steering Committee. Lancet 1997;350:161-165.
24. Phase I study of accelerated 3-dimensional conformal radiotherapy in patients with stage I non-small cell lung cancer with pulmonary dysfunction. CALGB-39904. Available at http://cancer.gov/search/viewclinicaltrials.aspx? cdrid=68409&version=healthprofessional&protocolserchid=1057893. Accessed July 2006.
25. Bogart J, Alpert T, Kilpatrick M, et al. Dose intensive thoracic radiotherapy for high-risk patients with early stage non-small lung cancer. Clin Lung Cancer 2006;6:350-354.
26. Rosenzweig KE, Dladla N, Schindelheim R, et al. Three-dimensional conformal radiation therapy (3D-CRT) for early-stage non-small-cell lung cancer. Clin Lung Cancer 2001;3:141-144.
27. Cheung PC, Yeung LT, Basrur V, et al. Accelerated hypofractionation for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;54:1014-1023.
28. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955.
29. Timmerman R, McGarry R, Papiez L, et al. Initial report of a prospective phase II trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2006;63 (Suppl 1):164.
30. A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. RTOG 0236. Available at http://rtog.org/summaries/lung.html. Accessed July 2006.
31. Onishi H, Nagata Y, Shirato H, et al. Stereotactic hypofractionated high-dose irradiationfor stage I non-small cell lung carcinoma: clinical outcomes in 273 cases of a Japanese multi-institutional study (Abstract). Proc Am Soc Clin Oncol 2004;23:617.
32. Fujino M, Shirato H, Onishi H, et al. Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors. Cancer J 2006;12:41-46.